{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:36:18Z","timestamp":1774049778340,"version":"3.50.1"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2020,2,26]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To quantify the implementation of the third Joint British Societies\u2019 Consensus Recommendations for the Prevention of Cardiovascular Disease (JBS3) after coronary event.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using a cross-sectional survey design, patients were consecutively identified in 36 specialist and district general hospitals between 6 months and 2 years, after acute coronary syndrome or revascularisation procedure and invited to a research interview. Outcomes included JBS3 lifestyle, risk factor and therapeutic management goals. Data were collected using standardised methods and instruments by trained study nurses. Blood was analysed in a central laboratory and a glucose tolerance test was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>3926 eligible patients were invited to participate and 1177 (23.3% women) were interviewed (30% response). 12.5% were from black and minority ethnic groups. 45% were persistent smokers, 36% obese, 52.9% centrally obese, 52% inactive; 30% had a blood pressure &gt;140\/90\u2009mm Hg, 54% non-high-density lipoprotein \u22652.5\u2009mmol\/L and 44.3% had new dysglycaemia. Prescribing was highest for antiplatelets (94%) and statins (85%). 81% were advised to attend cardiac rehabilitation (86% &lt;60\u2009years vs 79% \u226560 years; 82% men vs 77% women; 93% coronary artery bypass grafting vs 59% unstable angina), 85% attended if advised; 69% attended overall. Attenders were significantly younger (p=0.03) and women were less likely to attend (p=0.03).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with coronary heart disease (CHD) are not being adequately managed after event with preventive measures. They require a structured preventive cardiology programme addressing lifestyle, risk factor management and adherence to cardioprotective medications to achieve the standards set by the British Association for Cardiovascular Prevention and Rehabilitation and JBS3 guidelines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2019-001196","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:32:40Z","timestamp":1588221160000},"page":"e001196","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9143-1425","authenticated-orcid":false,"given":"Catriona S","family":"Jennings","sequence":"first","affiliation":[{"name":"NHLI, Imperial College London, London, UK"},{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornelia","family":"Kotseva","sequence":"additional","affiliation":[{"name":"NHLI, Imperial College London, London, UK"},{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bassett","sequence":"additional","affiliation":[{"name":"NHLI, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Adamska","sequence":"additional","affiliation":[{"name":"NHLI, Imperial College London, London, UK"},{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[{"name":"NHLI, Imperial College London, London, UK"},{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"2025081711082129000_7.1.e001196.1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.75.4.334"},{"key":"2025081711082129000_7.1.e001196.2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-301603"},{"key":"2025081711082129000_7.1.e001196.3","first-page":"ii1","article-title":"Joint British societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100 Suppl 2","author":"Boon","year":"2014","journal-title":"Heart"},{"key":"2025081711082129000_7.1.e001196.4","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015136"},{"key":"2025081711082129000_7.1.e001196.5","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2610"},{"key":"2025081711082129000_7.1.e001196.6","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0b013e3283294b1d"},{"key":"2025081711082129000_7.1.e001196.7","doi-asserted-by":"publisher","DOI":"10.1177\/2047487315569401"},{"key":"2025081711082129000_7.1.e001196.8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2025081711082129000_7.1.e001196.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.1.86"},{"key":"2025081711082129000_7.1.e001196.10","doi-asserted-by":"crossref","unstructured":"Anderson L , Taylor RS . Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2014:CD011273.doi:10.1002\/14651858.CD011273.pub2","DOI":"10.1002\/14651858.CD011273"},{"key":"2025081711082129000_7.1.e001196.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.891523"},{"key":"2025081711082129000_7.1.e001196.12","unstructured":"BACPR . The BACPR standards and core components for cardiovascular disease prevention and rehabilitation 2017. 3rd edn, 2017. http:\/\/www.bacpr.com\/resources\/BACPR_Standards_and_Core_Components_2017.pdf"},{"key":"2025081711082129000_7.1.e001196.13","unstructured":"The National audit of cardiac rehabilitation annual statistical report, 2018. Available: https:\/\/www.bhf.org.uk\/informationsupport\/publications\/statistics\/national-audit-of-cardiac-rehabilitation-quality-and-outcomes-report-2018"},{"key":"2025081711082129000_7.1.e001196.14","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"2025081711082129000_7.1.e001196.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"2025081711082129000_7.1.e001196.16","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025081711082129000_7.1.e001196.17","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.18.1950"},{"key":"2025081711082129000_7.1.e001196.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu051"},{"key":"2025081711082129000_7.1.e001196.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30272-0"},{"key":"2025081711082129000_7.1.e001196.20","unstructured":"NHS . Long term plan, 2019. Available: https:\/\/www.longtermplan.nhs.uk\/wp-content\/uploads\/2019\/01\/nhs-long-term-plan.pdf"},{"key":"2025081711082129000_7.1.e001196.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4439","article-title":"Weight gain in smokers after quitting cigarettes: meta-analysis","volume":"345","author":"Aubin","year":"2012","journal-title":"BMJ"},{"key":"2025081711082129000_7.1.e001196.22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv008"},{"key":"2025081711082129000_7.1.e001196.23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2016.12.125","article-title":"Lessons from contemporary trials of cardiovascular prevention and rehabilitation: a systematic review and meta-analysis","volume":"232","author":"van Halewijn","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025081711082129000_7.1.e001196.24","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310477"},{"key":"2025081711082129000_7.1.e001196.25","doi-asserted-by":"publisher","DOI":"10.1177\/2047487313498831"},{"key":"2025081711082129000_7.1.e001196.26","unstructured":"WHO . Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva: World Health Organisation, 2004. http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_894_(part1).pdf"},{"key":"2025081711082129000_7.1.e001196.27","unstructured":"Inoue S , Zimmet P . The Asia-Pacific perspective. redefining obesity and its treatment, 2000. Available: http:\/\/www.diabetes.com\/pdf\/obesity_report.pdf"},{"key":"2025081711082129000_7.1.e001196.28","article-title":"Godin leisure-time exercise questionnaire","volume":"29","author":"Godin","year":"1997","journal-title":"Med Sci Sports Exerc"},{"key":"2025081711082129000_7.1.e001196.29","unstructured":"NICE . Managing diabetes in patients with type 2 diabetes, 2019. Available: http:\/\/pathways.nice.org.uk\/pathways\/type-2-diabetes-in-adults"},{"key":"2025081711082129000_7.1.e001196.30","unstructured":"WHO . Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia [Internet], 2019. Available: https:\/\/www.who.int\/diabetes\/publications\/diagnosis_diabetes2006\/en\/ [Accessed 12 Jun 2019]."},{"key":"2025081711082129000_7.1.e001196.31","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.21.2508"},{"key":"2025081711082129000_7.1.e001196.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2025081711082129000_7.1.e001196.33","doi-asserted-by":"publisher","DOI":"10.1177\/2047487312450545"},{"key":"2025081711082129000_7.1.e001196.34","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.052787"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2019-001196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:08:29Z","timestamp":1755454109000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2019-001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,4,29]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/openhrt-2019-001196"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2019-001196","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}